| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 1.4 | 2.1 | 1.4 |
| Other income | 0.3 | 0.3 | 0.4 |
| Total income | 1.8 | 2.4 | 1.8 |
| Profit before exceptional items & tax | -0.6 | -0.1 | 0.3 |
| Profit before tax | -0.6 | -0.1 | 0.3 |
| Net profit | -0.6 | -0.1 | 0.3 |
| Operating margin | -33.3% | -4.2% | 16.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +0.00% |
|---|---|
| Operating profit, year on year | -800.00% |
| Operating profit, quarter on quarter | -125.00% |
BSE results filing, NSE: SHREEGANES. Figures extracted from the filing.
Shree Ganesh Bio-Tech (India) Ltd: key numbers
- Share price
- ₹0.47
- Market cap
- ₹18.74 Cr
- Revenue (annual)
- ₹4.97 Cr
- Net profit (annual)
- ₹0.38 Cr
- P/E (TTM)
- -48.5×Sector 50.4×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 1.42%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shree Ganesh Bio-Tech (India) Ltd
All →Shree Ganesh Bio-Tech (India) Annual Report
Shree Ganesh Bio-Tech (India) Limited has released its Annual Report for the financial year 2025-26. The 16th Annual General Meeting is scheduled for September 28, 2026.
Shree Ganesh Bio-Tech (India) Annual General Meeting
Shree Ganesh Bio-Tech (India) Limited has issued a notice for its 16th Annual General Meeting. The meeting is scheduled for September 28, 2026, at the registered office.
Shree Ganesh Bio-Tech (India) Q4 FY26 Results: Net Loss of ₹0.1 Cr, Loss Narrows
Shree Ganesh Bio-Tech (India) Ltd reported revenue from operations of ₹2.1 Cr (-30.0% YoY) and a net loss of ₹0.1 Cr for Q4 FY26.
- Key figure
- Net loss ₹0.1 Cr